News

Exyte Projects Portfolio: Mycenax Jhunan factory II project - building biotech excellence in Taiwan

【Warmth in Every Touch】Mycenax Partners with Shuaixin Blind Association to Launch Long-Term Wellness Initiative

From Development Experts to Global CDMO Partners: Insights from our CEO, Dr. Pei-Jiun Chen

Mycenax Ignites Long-Term Growth with Commercial Manufacturing and Strategic Japan Joint Venture

Nikkei Biotech's Interview: Mycenax’s Strategic Blueprint for Japan, ADC, and Beyond

Signing of an Agreement to Establish a Joint Venture for the Manufacture of Biosimilars

Mycenax and RIN Sign License Agreement to Advance ADC Development Using RIN's Proprietary Linker Technology

Mycenax Entered into Non-binding Term Sheet with Japanese Strategic Partners to Advance the Plan of Building Manufacturing Facility and CDMO Business in Japan

Mycenax and SPERA PHARMA Forge Strategic Alliance to Streamline ADC Drug Substance and Drug Product Manufacturing Services

Mycenax Achieves CDMO Transformation Milestones with International Marketing Approvals and Global Expansion